Regulation of complement C3 expression by the bile acid receptor FXR. (Q38333321)

2 September 2017

title

Regulation of complement C3 expression by the bile acid receptor FXR. (English)

1 reference

2 September 2017

Jiali Li

1 reference

2 September 2017

Parinaz C Pircher

series ordinal

1 reference

2 September 2017

Ira G Schulman

series ordinal

1 reference

2 September 2017

Stefan K Westin

series ordinal

1 reference

2 September 2017

language of work or name

English

0 references

publication date

7 December 2004

1 reference

Journal of Biological Chemistry

2 September 2017

1 reference

inferred from page(s)

published in

1 reference

2 September 2017

volume

280

1 reference

2 September 2017

1 reference

2 September 2017

page(s)

7427-7434

1 reference

A unified nomenclature system for the nuclear receptor superfamily

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

The nuclear receptor superfamily: the second decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Nuclear receptors and lipid physiology: opening the X-files

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Identification of a nuclear receptor for bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Bile acids: natural ligands for an orphan nuclear receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Farnesoid X Receptor Regulates Bile Acid-Amino Acid Conjugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Chenodeoxycholic acid therapy for hypertriglyceridaemia in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

The farnesoid X-receptor is an essential regulator of cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Identification of a chemical tool for the orphan nuclear receptor FXR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Mouse FGF15 is the ortholog of human and chick FGF19, but is not uniquely required for otic induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Critical review of acylation-stimulating protein physiology in humans and rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Human C′3: Evidence for the Liver as the Primary Site of Synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Increased expression of complement component C3 in the plasma of obese Zucker fa and LA/N fa(f) rats compared with their lean counterparts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Influence of C3 deficiency on atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M411473200

21 January 2018

Identifiers

DOI

10.1074/JBC.M411473200

1 reference

2 September 2017

1 reference